期刊文献+

人血管内皮细胞生长因子D在口腔鳞癌中的表达及意义 被引量:2

Expression and Significance of Vascular Endothelial Growth Factor D in Oral Squamous Cell Carcinoma
下载PDF
导出
摘要 目的探讨人血管内皮细胞生长因子D(VEGF-D)在口腔鳞癌组织中的表达及其与口腔鳞癌临床病理特征之间的关系。方法 2006年10月—2009年10月贵阳医学院附属医院口腔颌面外科住院口腔鳞癌患者手术切除标本60例,癌旁口腔组织标本32例,同时选取正常口腔组织12例。采用免疫组织化学染色法(SABC法)检测口腔鳞癌组织、癌旁口腔组织和正常口腔组织中VEGF-D的表达,同时分析VEGF-D与患者临床病理特征的关系。采用SPSS 12.0统计软件进行统计学分析,计数资料采用χ2检验。结果 VEGF-D在口腔鳞癌组织、癌旁口腔组织及正常口腔组织中的阳性表达率分别是43.3%(26/60)、84.3%(27/32)、8.3%(1/12)。癌旁口腔组织中VEGF-D的阳性表达率较口腔鳞癌组织和正常口腔组织均明显升高,差异有统计学意义(χ2值分别为14.395和18.645,P<0.05);口腔鳞癌组织中VEGF-D的阳性表达率较正常口腔组织明显升高,差异有统计学意义(P=0.025)。TNM分期Ⅰ/Ⅱ期和Ⅲ/Ⅳ期口腔鳞癌组织中VEGF-D阳性表达率比较,差异有统计学意义(χ2=5.279,P<0.05);有淋巴结转移和无淋巴结转移口腔鳞癌组织中VEGF-D阳性表达率比较,差异有统计学意义(χ2=6.007,P<0.05)。结论 VEGF-D在口腔鳞癌组织及癌旁口腔组织中高表达,癌旁口腔组织中的表达率最高,提示其与肿瘤的侵袭性生长有关。VEGF-D在口腔鳞癌中的表达与淋巴结转移密切相关,VEGF-D可促使口腔鳞癌发生淋巴结转移。 Objective To investigate the expression of vascular endothelial growth factor D ( VEGF - D) in oral squa- mous cell carcinoma and its relationship with clinical pathological characteristics of oral squamous cell carcinoma (OSCC). Methods 60 surgical samples of OSCC patients admitted to the Department of Oral Medicine of the Affiliated Hospital of Guiyang Medical College from October 2006 to October 2009, 32 samples of paraneoplastic tissues and 12 samples of normal oral tissues were involved into the study. Immunohistochemical staining (SABC) was used to detect the expression of VEGF - D in oral carci- noma tissues, paraneoplastic tissues and normal oral tissues, and the results were analyzed combined with the patients' clinieo- pathologic indexes. SPSS 12.0 statistical software was used to make statistics analysis and enumeration data was tested by X2. Results The positive expression rates of VEGF - D in OSCC tissues, oral paraneoplastic tissues and normal oral tissues were 43.3% (26/60), 84. 3% (27/32) and 8. 3% (1/12) . The expression rate of VEGF - D in paraneoplastic tissues was significantly increased compared with that in OSCC tissues and normal oral tissues (X2 was 14. 395 and 18. 645 respectively, P 〈 0. 05 ). The expression of VEGF - D in OSCC tissues was significantly increased compared with that in normal oral tissues ( P = 0. 025 ). The VEGF- D protein positive rate between TNM I/II stage and TNM III/IV stage showed statistically significant difference ( X2 = 5. 279, P 〈 0.05) . The VEGF - D protein positive rate between OSCC tissues with lymph node metastasis and OSCC tissues without lymph node metastasis showed statistically significant difference ( X2 = 6. 007, P 〈 0. 05 ) . Conclusion VEGF- D has high expression in OSCC tissues and paraneoplastic tissues, especially higher in the latter one, indicating that it may relate to invasive growth of the tumor. The expression of VEGF - D is closely related to lymph node metastasis and VEGF - D can promote lymph node metastasis.
作者 段晓峰
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第27期3142-3145,共4页 Chinese General Practice
基金 国家自然科学基金(30660200) 贵州省省长专项资金项目[(2005)160号]
关键词 口腔肿瘤 人血管内皮细胞生长因子D 淋巴结转移 Mouth neoplasms Vascular endothelial growth factor D Lymph node metastasis
  • 相关文献

参考文献11

  • 1Tobler N, Detmar M. Tumor and lymph node lymphangiogenesis - impact on cancer metastasis [J]. J Leukoc Biol, 2006, 80 (4): 691- 696.
  • 2Hinojar - Gutierrez A, Fernandez - Contreras ME, Gonzalez - Gonzalez R, et al. Intratumoral lymphatic vessels and VEGF - C expression are predictive factors of lymph node relapse in Tl - T4 NO laryngopharyngeal squamous cell carcinoma [J]. Ann Surg Oneol, 2007, 14 (1): 248 - 257.
  • 3Yokoyama Y, Charnock -Jone DS, Licence D, et al. Expression of vascular endothelial growth factor (VEGF) - D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma [ J ]. Clin Cancer Res, 2003, 9 (4) : 1361 - 1369.
  • 4Partanen TA, Arola J, Saaristo A, et al. VEGF-C and VEGF -D ex- pression in neuroendocrine cells and their receptor, VEGFR - 3, in fe- nestrated blood vessels in human tissues [ J ]. FASEB J, 2000, 14 ( 13 ) : 2087 - 2096.
  • 5Lee J, Hwan Kim K, Kim H. Role of vascular endothelial growth factor - D ( VEGF - D ) on IL - 6 expression in cerulein - stimulated oral squamous cell carcinoma [J]. Ann N Y Acad Sci, 2007, 1095:129 - 133.
  • 6Mc Coil BK, Baldwin ME, Roufail S, et al. Activates the lymphangio- genic growth factors VEGF - C and VEGF - D [ J~. J Exp Med, 2003, 198 (6): 863-868.
  • 7Van der Auwera I, Van den Eynden GG, Colpaert CG, et al. Tumor lymphanglogenesis in inflammatory breast carcinoma: a histomorphomet- ric study [J]. Clin Cancer Res, 2005, 11 (21) : 7637 -7642.
  • 8Orlandini M, Marconcini L, Ferruzzi R, et al. Identification of a c - los- induced gene that is related to the platelet - derived growth factor/vas- cular endothelial growth factor family [ J ]. Proc Natl Acad Sci USA, 1996, 93 (21): 11675-11680.
  • 9Achen MG, Jeltsch M, Kukk E, et al. Vascular endothelial growth fac- tor D ( VEGF - D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flkl) and VEGF receptor3 (Fit4) [J]. Proc Natl Acad Sci USA, 1998, 95 (2): 548-553.
  • 10Yamada Y, Nezu J, Shimane M, et al. Molecular cloning of a novel vascular endothelial growth factor, VEGF - D [ J ]. Genomics, 1997, 42 (3): 483-488.

同被引文献30

  • 1Aroor AR, Demarco VG, Jia G, et al. The role of tissue Renin - Angiotensin - aldosterone system in the development of endothelial dysfunction and arterial stiffness [ J ]. Front Endocrinol (Lausanne) , 2013, 4: 161.
  • 2Coultas L, Chawengsaksophak K, Rossant J. Endothelial ceils and VEGF in vascular development [ J ]. Nature, 2005, 438 (7070) : 937 - 945.
  • 3ho I, Fixman ED, Asai K, et al. Platelet- derived growth factor and transforming growth factor - beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells [J]. Clin Exp Allergy, 2009, 39 (9) : 1370 - 1380.
  • 4Liu C, Zhao W, Meng W, et al. Platelet - derived growth factor blockade on cardiac remodeling following infarction [ J ]. Mol Cell Biochem, 2014, 397 (1/2): 295-304.
  • 5Bijnsdorp IV, Capriotti F, Kruyt FA, et al. Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors [J]. Br J Cancer, 2011 , 104(7): 1185 -1192.
  • 6Hermanson M, Funs K, Hartman M, et al. Platelet - derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops [J]. Cancer Res, 1992, 52 (11) : 3213 -3219.
  • 7Heldin CH, Westermark B. Mechanism of'action and in vivo role of platelet - derived growth factor [ J ]. Physiol Rev, 1999, 79 (4) : 1283 - 1316.
  • 8Wang H ,. Yin Y, Li W, et al. Over - expression of PDGFR - beta promotes PDGF - induced proliferation, migration, and angiogenesis of EPCs through PI3 K/Akt signaling pathway [ J]. PLoS One, 2012, 7 (2) : e30503.
  • 9Son JE, Jeong H, Kim H, et al. Pelargonidin attenuates PDGF - BB -induced aortic smooth muscle cell proliferation and migration by direct inhibition of focal adhesion kinase [ J ]. Biochem Pharmacol, 2014, 89 (2): 236-245.
  • 10Bilder G, Wentz T, Leadley R, et al. Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF -receptor tyrosine kinase inhibitor, RPR10i511A [J]. Circulation, 1999, 99 (25): 3292-3299.

引证文献2

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部